Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 229

1.

Effect of obstructive sleep apnea on the response to hypertension therapy.

Ziegler MG, Milic M, Lu X, Gharaibeh M, Elayan H.

Clin Exp Hypertens. 2017;39(5):409-415. doi: 10.1080/10641963.2016.1259327. Epub 2017 May 30.

PMID:
28557555
2.

Investigation of a Potential Pharmacokinetic Interaction Between Nebivolol and Fluvoxamine in Healthy Volunteers.

Gheldiu AM, Vlase L, Popa A, Briciu C, Muntean D, Bocsan C, Buzoianu A, Achim M, Tomuta I, Todor I, Neag M.

J Pharm Pharm Sci. 2017;20:68-80. doi: 10.18433/J3B61H.

3.

The Comparison of the Effects of Nebivolol and Metoprolol on Erectile Dysfunction in the Cases with Coronary Artery Bypass Surgery.

Gür Ö, Gurkan S, Yumun G, Turker P.

Ann Thorac Cardiovasc Surg. 2017 Apr 20;23(2):91-95. doi: 10.5761/atcs.oa.16-00242. Epub 2017 Mar 10.

4.

Efficacy of nebivolol-valsartan single-pill combination in obese and nonobese patients with hypertension.

Mende CW, Giles TD, Bharucha DB, Ferguson WG, Mallick M, Patel MD.

J Clin Hypertens (Greenwich). 2017 Jun;19(6):632-639. doi: 10.1111/jch.12965. Epub 2017 Jan 11.

6.
7.

Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study.

Grassi G, Seravalle G, Brambilla G, Dell'Oro R, Trevano FQ, Fici F, van Bortel L, Mancia G.

Adv Ther. 2017 Jan;33(12):2173-2187. Epub 2016 Oct 22.

PMID:
27771847
8.

Differential effects of nebivolol vs. metoprolol on microvascular function in hypertensive humans.

Velasco A, Solow E, Price A, Wang Z, Arbique D, Arbique G, Adams-Huet B, Schwedhelm E, Lindner JR, Vongpatanasin W.

Am J Physiol Heart Circ Physiol. 2016 Jul 1;311(1):H118-24. doi: 10.1152/ajpheart.00237.2016. Epub 2016 May 13.

9.

Nebivolol versus Carvedilol or Metoprolol in Patients Presenting with Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction.

Ozaydin M, Yucel H, Kocyigit S, Adali MK, Aksoy F, Kahraman F, Uysal BA, Erdogan D, Varol E, Dogan A.

Med Princ Pract. 2016;25(4):316-22. doi: 10.1159/000446184. Epub 2016 May 10.

10.

Chronic Nebivolol Treatment Suppresses Endothelin-1-Mediated Vasoconstrictor Tone in Adults With Elevated Blood Pressure.

Diehl KJ, Stauffer BL, Dow CA, Bammert TD, Brunjes DL, Greiner JJ, DeSouza CA.

Hypertension. 2016 Jun;67(6):1196-204. doi: 10.1161/HYPERTENSIONAHA.115.06979. Epub 2016 Apr 25.

11.

Comprehensive Assessment of Coronary Plaque Progression With Advanced Intravascular Imaging, Physiological Measures, and Wall Shear Stress: A Pilot Double-Blinded Randomized Controlled Clinical Trial of Nebivolol Versus Atenolol in Nonobstructive Coronary Artery Disease.

Hung OY, Molony D, Corban MT, Rasoul-Arzrumly E, Maynard C, Eshtehardi P, Dhawan S, Timmins LH, Piccinelli M, Ahn SG, Gogas BD, McDaniel MC, Quyyumi AA, Giddens DP, Samady H.

J Am Heart Assoc. 2016 Jan 25;5(1). pii: e002764. doi: 10.1161/JAHA.115.002764.

12.

Nebivolol Effects on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients.

Santos AH Jr, Casey MJ, Bucci CM, Rehman S, Segal MS.

J Clin Hypertens (Greenwich). 2016 Aug;18(8):741-9. doi: 10.1111/jch.12745. Epub 2015 Dec 22.

13.

Impact of Carvedilol versus β1-selective β blockers (bisoprolol, metoprolol, and nebivolol) in patients with acute myocardial infarction undergoing percutaneous coronary intervention.

Seo GW, Kim DK, Kim KH, Seol SH, Jin HY, Yang TH, Ahn Y, Jeong MH, Song PS, Kim DI; Other Korea Acute Myocardial Infarction Registry Investigators.

Am J Cardiol. 2015 Nov 15;116(10):1502-8. doi: 10.1016/j.amjcard.2015.08.013. Epub 2015 Aug 31.

PMID:
26520013
14.

Nebivolol compared with metoprolol for erectile function in males undergoing coronary artery bypass graft.

Aldemir M, Keleş İ, Karalar M, Tecer E, Adalı F, Pektaş MB, Parlar Aİ, Darçın OT.

Anatol J Cardiol. 2016 Feb;16(2):131-6. doi: 10.5152/akd.2015.5936. Epub 2015 Feb 11.

15.

Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension.

Giles TD, Bakris G, Oparil S, Weber MA, Li H, Mallick M, Bharucha DB, Chen C, Ferguson WG; NAC-MD-01 Substudy Investigators.

J Am Soc Hypertens. 2015 Nov;9(11):845-54. doi: 10.1016/j.jash.2015.08.003. Epub 2015 Aug 12.

16.

Nitric Oxide Contributes to Vasomotor Tone in Hypertensive African Americans Treated With Nebivolol and Metoprolol.

Neuman RB, Hayek SS, Poole JC, Rahman A, Menon V, Kavtaradze N, Polhemus D, Veledar E, Lefer DJ, Quyyumi AA.

J Clin Hypertens (Greenwich). 2016 Mar;18(3):223-31. doi: 10.1111/jch.12649. Epub 2015 Aug 19.

17.

Ambulatory 24-hour cardiac oxygen consumption and blood pressure-heart rate variability: effects of nebivolol and valsartan alone and in combination.

Izzo JL Jr, Khan SU, Saleem O, Osmond PJ.

J Am Soc Hypertens. 2015 Jul;9(7):526-35. doi: 10.1016/j.jash.2015.03.009. Epub 2015 Mar 28.

PMID:
26116459
18.

Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.

Bocchi EA, Böhm M, Borer JS, Ford I, Komajda M, Swedberg K, Tavazzi L; SHIFT investigators.

Cardiology. 2015;131(4):218-24. doi: 10.1159/000380812. Epub 2015 May 12.

19.

A Single-Center, Open-Label, 3-Way Crossover Trial to Determine the Pharmacokinetic and Pharmacodynamic Interaction Between Nebivolol and Valsartan in Healthy Volunteers at Steady State.

Chen CL, Desai-Krieger D, Ortiz S, Kerolous M, Wright HM, Ghahramani P.

Am J Ther. 2015 Sep-Oct;22(5):e130-40. doi: 10.1097/MJT.0000000000000247.

20.

Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension.

Mose FH, Jensen JM, Therwani S, Mortensen J, Hansen AB, Bech JN, Pedersen EB.

Br J Clin Pharmacol. 2015 Sep;80(3):425-35. doi: 10.1111/bcp.12627. Epub 2015 Jun 5.

Supplemental Content

Loading ...
Support Center